BioHarvest Sciences Inc. (BHST)
NASDAQ: BHST · Real-Time Price · USD
8.76
+0.66 (8.15%)
At close: Aug 8, 2025, 4:00 PM
9.14
+0.38 (4.34%)
After-hours: Aug 8, 2025, 7:51 PM EDT

Company Description

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States.

It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients.

It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions.

The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine.

The company is based in Vancouver, Canada.

BioHarvest Sciences Inc.
CountryCanada
Founded2007
IndustryPackaged Foods
SectorConsumer Staples
Employees2
CEOIlan Sobel

Contact Details

Address:
1140-625 Howe Street
Vancouver, BC V6C 2T6
Canada
Phone604 689 5722
Websitebioharvest.com

Stock Details

Ticker SymbolBHST
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001723464
ISIN NumberCA09076J2074
SIC Code2834

Key Executives

NamePosition
Ilan SobelChief Executive Officer
Dr. Zaki Rakib Ph.D.Co-Founder, Executive Chairman and President
Dr. Yoheved Hagay Ph.D.Co-Founder, Chief Technology Officer and Member of Scientific Advisory Board
Dr. Ilana Belzer Ph.D.Chief Operating Officer
David K. RyanVice President of Investor Relations and Secretary
Bar DichterChief Financial Officer
Dr. Malkit Azachi Ph.D.Vice President of Research and Development
Michal Abargel SapirVice President of Regulatory Affairs
Jared TurnerVice President of D2C Products Business Unit

Latest SEC Filings

DateTypeTitle
Aug 5, 20256-KReport of foreign issuer
Jul 23, 20256-KReport of foreign issuer
Jul 23, 2025S-8Securities to be offered to employees in employee benefit plans
Jul 7, 20256-KReport of foreign issuer
Jul 3, 20256-KReport of foreign issuer
Jun 10, 20256-KReport of foreign issuer
Jun 4, 20256-KReport of foreign issuer
May 21, 20256-KReport of foreign issuer
May 15, 20256-KReport of foreign issuer
May 15, 20256-KReport of foreign issuer